Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Stalevo, levodopa/carbidopa/entacapone
Also known as: Combination tablet of levodopa, carbidopa and entacapone
print preview
bookmark
share with colleague
General Information
Company
Orion Corp.
Description
Levodopa plus dopa decarboxylase inhibitor and catechol-O-methyl-transferase (COMT) inhibitor
Molecular Target
Dopamine receptor
Mechanism of Action
Dopamine receptor agonist
Latest Stage of Development
Marketed
Indication
Parkinson's disease (PD)
Partner
Novartis AG
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy